FASN and metabolic disease: It is also the first to describe the interconnection between FASN and CD36 and provides a strong rationale for further investigation into the interconnection of de novo lipogenesis and FA uptake that could potentially lead to the development of new therapeutic strategies for CRC and other solid malignancies, and potentially some metabolic disorders as well.